⌘K

Home/Filings/4/0001104659-22-130165

4//SEC Filing

DRISCOLL JOSEPH 4

Accession 0001104659-22-130165

CIK 0001711933other

View on SEC.gov Company Profile

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 4:05 PM ET

Size

6.8 KB

Accession

0001104659-22-130165

Insider Transaction Report

Form 4

Period: 2022-12-22

Akoya Biosciences, Inc.AKYA

DRISCOLL JOSEPH

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2022-12-22$0.44/sh+250,000$110,000→ 262,500 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-12-22−250,000→ 110,958 total
Exercise: $0.44Exp: 2029-05-02→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]The option will be fully vested on 03/18/2023.

Documents

1 file

4
tm2233541-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1

filerCIK 0001392297

Filing Metadata

Form type: 4
Filed: Dec 26, 7:00 PM ET
Accepted: Dec 27, 4:05 PM ET
Size: 6.8 KB

View on SEC.gov